Table 5.
Antibiotic susceptibility test results for isolated Salmonella strains (n = 7)
| Antibiotic (dose) | Resistance (%) | Susceptibility (%) | p-value | |
|---|---|---|---|---|
| Amoxicillin (AM, 10 µg) | 28.57 | 71.43 | 0.4531 | |
| Amoxicillin + Clavulanic acid (AMC, 20 µg) | 28.57 | 71.43 | 0.4531 | |
| Ticarcillin (TC, 75 µg) | 0.00 | 100.00 | 0.0156 | |
| Ticarcillin + Clavulanic acid (TCC, 75/10 µg) | 0.00 | 100.00 | 0.0156 | |
| Piperacillin (PRL, 30 µg) | 0.00 | 100.00 | 0.0156 | |
| Cefalexin (CL, 30 µg) | 28.57 | 71.43 | 0.4531 | |
| Cefoxitin (FOX, 30 µg) | 14.29 | 85.71 | 0.1250 | |
| Cefuroxime (CXM, 30 µg) | 28.57 | 71.43 | 0.4531 | |
| Ceftazidime (CAZ, 10 µg) | 28.57 | 71.43 | 0.4531 | |
| Ceftriaxone (CTR, 30 µg) | 28.57 | 71.43 | 0.4531 | |
| Cefepime (CEF, 30 µg) | 0.00 | 100.00 | 0.0156 | |
| Aztreonam (ATM, 30 µg) | 28.57 | 71.43 | 0.4531 | |
| Imipenem (IPM, 10 µg) | 0.00 | 100.00 | 0.0156 | |
| Ertapenem (ETP, 10 µg) | 0.00 | 100.00 | 0.0156 | |
| Amikacin (AK, 30 µg) | 0.00 | 100.00 | 0.0156 | |
| Gentamicin (GEN, 10 µg) | 0.00 | 100.00 | 0.0156 | |
| Tobramycin (TOB, 10 µg) | 0.00 | 100.00 | 0.0156 | |
| Netilmicin (NET, 30 µg) | 0.00 | 100.00 | 0.0156 | |
| Chloramphenicol (C, 30 µg) | 0.00 | 100.00 | 0.0156 | |
| Trimethoprim-sulfamethoxazole (SXT, 1.25/23.75 µg) | 0.00 | 100.00 | 0.0156 | |
| Nalidixic acid (NA, 30 µg) | 28.57 | 71.43 | 0.4531 | |
| Ofloxacin (OFX, 30 µg) | 0.00 | 100.00 | 0.0156 | |
| Norfloxacin (NOR, 30 µg) | 0.00 | 100.00 | 0.0156 | |
| Ciprofloxacin (CIP, 5 µg) | 0.00 | 100.00 | 0.0156 | |
| Fosfomycin (FF, 200 µg) | 0.00 | 100.00 | 0.0156 | |
| Nitrofurantoin (N, 100 µg) | 0.00 | 100.00 | 0.0156 |